Cite
HARVARD Citation
Taylor, R. et al. (n.d.). Hexamerization-enhanced CD37 and CD20 antibodies synergize in CDC to kill patient-derived CLL cells with unprecedented potency. Molecular immunology. pp. 218-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Taylor, R. et al. (n.d.). Hexamerization-enhanced CD37 and CD20 antibodies synergize in CDC to kill patient-derived CLL cells with unprecedented potency. Molecular immunology. pp. 218-. [Online].